» Articles » PMID: 2450832

Analysis of Immunity to Infection with Salmonella Typhimurium in Outbred Mice. I. Requirement of the Antibody to Non-O Antigen for Protection in Mice That Are Not Protected by the RNA-rich Vaccine

Overview
Journal Immunology
Date 1987 Aug 1
PMID 2450832
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Two outbred mouse strains, ddY and CF1, were tested for their ability to be protected against infection with Salmonella typhimurium by several types of salmonella vaccines. These strains have the same levels of innate susceptibility to S. typhimurium, and also have the same capacity to develop delayed-type hypersensitivity (DTH) to salmonella antigens. Both the crude ribosomal fraction (CRF) and live-cell vaccines conferred acquired resistance on both strains, characterized by greater responses of T cells to salmonella antigens. Mice of the ddY strain were also protected by the purified transfer RNA (tRNA) vaccine, which was free of O antigens, but CF1 mice were not, despite the presence of T-cell reactivity with salmonella antigens. Neither strain was protected by the phenol-water-extracted lipopolysaccharide (LPS). The tRNA-immunized CF1 mice were protected by transfer of antiserum to CRF, but not by transfer of anti-LPS antibody. This antiserum to CRF, however, did not transfer acquired resistance into non-immune mice of either strain. These observations suggest that CF1 mice may require an antibody to another non-O antigen existing in CRF to develop acquired resistance, and that stimulation of the defence system by tRNA may be essential to the development of acquired resistance in CF1 mice.

Citing Articles

Mouse models to assess the efficacy of non-typhoidal Salmonella vaccines: revisiting the role of host innate susceptibility and routes of challenge.

Simon R, Tennant S, Galen J, Levine M Vaccine. 2011; 29(32):5094-106.

PMID: 21616112 PMC: 3152302. DOI: 10.1016/j.vaccine.2011.05.022.


Analysis of immunity to infection with Salmonella typhimurium in outbred mice. II. Isolation and immunogenicity of the protective non-O antigenic component from ribosomal vaccine.

Kita E, Emoto M, KATSUI N, Nishi K, Yasui K, KASHIBA S Immunology. 1987; 62(2):235-40.

PMID: 2445665 PMC: 1453966.

References
1.
Collins F . Vaccines and cell-mediated immunity. Bacteriol Rev. 1974; 38(4):371-402. PMC: 413869. DOI: 10.1128/br.38.4.371-402.1974. View

2.
Plant J, GLYNN A . Genetics of resistance to infection with Salmonella typhimurium in mice. J Infect Dis. 1976; 133(1):72-8. DOI: 10.1093/infdis/133.1.72. View

3.
Misfeldt M, Johnson W . Variability of protection in inbred mice induced by a ribosomal vaccine prepared from Salmonella typhimurium. Infect Immun. 1976; 14(3):652-9. PMC: 420936. DOI: 10.1128/iai.14.3.652-659.1976. View

4.
Kita E, KASHIBA S . Immunogenicity of transfer RNA isolated from a two-heptose rough mutant of Salmonella typhimurium LT2 in mouse typhoid infection. Immunology. 1983; 50(3):369-76. PMC: 1454259. View

5.
Julius M, Simpson E, Herzenberg L . A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol. 1973; 3(10):645-9. DOI: 10.1002/eji.1830031011. View